SCHEMBL23217100

SCHEMBL23217100

CC(=O)Nc1ccc(S(=O)(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)cc1

nearest known ligand 0.70

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.70
ALDH1A1 P00352 3/20 0.70
KDM4E B2RXH2 2/20 0.70
POLB P06746 1/20 0.66
KDM4C Q9H3R0 1/20 0.66
TDP1 Q9NUW8 1/20 0.66
ATM Q13315 1/20 0.64
HTT P42858 3/20 0.62
LMNA P02545 2/20 0.62
GAA P10253 2/20 0.62
SMN1; SMN2 Q16637 2/20 0.62
KMT2A Q03164 4/20 0.60
MEN1 O00255 3/20 0.60
TRPV4 Q9HBA0 1/20 0.60
HTR2A P28223 1/20 0.60
PAX8 Q06710 1/20 0.59
PKM P14618 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23217016 0.88 HTT (0.60) MAPTALDH1A1KDM4EPOLBHTT
SCHEMBL23217034 0.88 MAPT (0.57) MAPTALDH1A1KDM4EPOLBHTT
SCHEMBL30889350 0.88 MAPT (0.57) MAPTALDH1A1KDM4EPOLBHTT
SCHEMBL1870289 0.87 F13A1 (0.72) MAPTALDH1A1HTTLMNAGAA
SCHEMBL25381894 0.86 MAPT (0.66) MAPTALDH1A1KDM4EKDM4CTDP1
SCHEMBL30563199 0.86 MAPT (0.66) MAPTALDH1A1KDM4EKDM4CTDP1
SCHEMBL30889354 0.86 ALDH1A1 (0.58) MAPTALDH1A1KDM4EPOLBKDM4C
SCHEMBL23217102 0.86 ALDH1A1 (0.58) MAPTALDH1A1KDM4EPOLBKDM4C
SCHEMBL30006605 0.84 TRPV4 (0.57) MAPTALDH1A1KDM4EPOLBHTT
SCHEMBL30005853 0.84 TRPV4 (0.57) MAPTALDH1A1KDM4EPOLBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240124400-A1 LPXH TARGETING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME DUKE UNIVERSITY (US) 2024-04-18 US disclosed
WO-2021072369-A1 LPXH TARGETING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME DUKE UNIVERSITY (US) 2021-04-15 WO disclosed
WO-2021072369-A1 LPXH TARGETING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME DUKE UNIVERSITY (US) 2021-04-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240124400-A1 LPXH TARGETING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME CFH, LPAR3, CBR3 MAPT 4754/4885ALDH1A1 3931/4885KDM4E 2296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.